Structure May Determine Toxicity of Huntingtin Aggregates
2006).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2141 Triplet Repeat Diseases Huntingtin
373 RESULTS
You searched Landhuis
Sort By:
2006).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2141 Triplet Repeat Diseases Huntingtin
latest from this $64-million initiative in a two-part series by Esther Landhuis. American Academy of
especially if it’s taxpayer-supported. Scientists don’t own their data.”—Esther Landhuis. This concludes our
strength for the duration of the study,” she said.—Esther Landhuis. This is Part 1 of a two-part series.
relative utility of various AD biomarker approaches. Stay tuned for the skinny on that.—Esther Landhuis
and Reiman et al., 2009).—Esther Landhuis. This is Part 3 of a four-part series. See Part 1, Part 2,
pick up subtle cognitive deficits that escape standard measures.—Esther Landhuis. This is Part 2 of
more.—Esther Landhuis. This is Part 1 of a four-part series. See Part 2, Part 3, and Part 4. All attendees are
beyond which the animals cannot deposit amyloid,” Morgan said.—Esther Landhuis None
congratulations to this year’s awardees!—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=2111
has not yet been considered.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2105
received information about their ApoE gene status (see ARF Live Discussion).—Esther Landhuis. None
for AD.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2100 Alzheimer's Disease
mechanism.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2099 Alzheimer's Disease Aβ Ion
target is “totally different” from those of other AD drug candidates, Lipton said.—Esther Landhuis None